A “bioadaptive” stent might circumvent the slow accumulation of target lesion failure that has been a consistent weakness of ...

Abbott, Medtronic, Boston Scientific Corporation ... the market is segmented based on product type (drug-eluting stent (DES), ...

To improve the management of coronary artery disease and lay the groundwork for future advancements in stent technology, ...

The global coronary artery bypass graft market, valued at USD 17,612.1 million in 2023, is forecast to experience significant growth, reaching an estimated USD 22,765.9 million by 2033. While the ...

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final two rounds ...

The 2024 edition of Transcatheter Cardiovascular Therapeutics (TCT) once again highlighted significant innovations in ...

Hello Health Rounds Readers! Today we have three studies presented at medical meetings, including one testing a device that ...

India Cardiovascular Devices Market is flourishing due to increasing prevalence of cardiovascular diseases, rapidly aging population, and the government’s initiatives and regulations aimed at ...

Results from the large-scale randomized ECLIPSE trial found that a lesion preparation strategy of routine orbital atherectomy had similar outcomes compared with conventional balloon angioplasty prior ...

Data highlighted the success of DynamX compared to Medtronic’s Resolute Onyx zotarolimus drug-eluting stent (DES). The study ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

Moderate Sedation is Associated with Better Cognitive Function Compared with General Anesthesia in Patients Undergoing LAAO: Prospective Evaluation Using Novel Digital Oculomotor Biomarkers Receive ...